Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial
Glenda E. Gray*, Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural, Ollivier Hyrien, Michal Juraska, Alex Luedtke, Philipp Mann, M. Juliana McElrath, Jackline A. Odhiambo, Daniel J. Stieh, Janine van Duijn, Azwidihwi N. Takalani, Wouter Willems, Asa Tapley, Georgia D. Tomaras, Johan Van Hoof, Hanneke SchuitemakerEdith Swann, Dan H. Barouch, James G. Kublin, Lawrence Corey, Maria G. Pau, Susan Buchbinder, Frank Tomaka, Jon Allagappen, Jessica Andriesen, Alison Ayres, Linda Gail Bekker, Caroline Borremans, William Brumskine, Roma Chilengi, Thozama Dubula, Nigel Garrett, Huub Gelderblom, Katherine Gill, Zaheer Hoosain, Mina Hosseinipour, Julia Hutter, Mubiana Inambao, Craig Innes, William Kilembe, Philippus Kotze, Sheena Kotze, Fatima Laher, Imre Laszlo, Erica Lazarus, Mookho Malahleha, Matsontso Mathebula, Mitch Matoga, Rachael McClennen, Pamela Mda, Peter Meerts, Vimla Naicker, Logashvari Naidoo, Tricia Philip, Annah Pitsi, Lorenz Scheppler, Carrie Sopher, Simbarashe G. Takuva, Edna Viegas, Mo Weijtens, Olive Yuan
Research output: Contribution to journal › Article › peer-review
6Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial'. Together they form a unique fingerprint.